M/14/004 – Crimson / OCD
Transaction details
The proposed acquisition of sole control of the Ortho Clinical Diagnostics business by Crimson Bermuda Co. Limited has been cleared by the Competition Authority.
| Notification date | Decision date |
|---|---|
| Tuesday February 4, 2014 | Thursday, February 27, 2014 |
| Parties Involved | Business activities |
|---|---|
| Crimson Bermuda Co. Ltd | Crimson is a company controlled by funds managed by affiliates of The Carlyle Group. Carlyle is a global alternative asset manager. |
| Ortho Clinical Diagnostics | OCD is a provider of IVD systems. |
| Economic sector | Media merger |
|---|---|
| The in-vitro diagnostic (IVD) sector. | No |
| Submissions from third parties due by: | |
|---|---|
| Phase 1 | Phase 2 |
| Monday, February 17, 2014 | |
| Current status: Completed |
|---|
| Cleared (Phase 1) |
| Authorised Officer Assigned | Contact Details |
|---|---|
| Elaine Cahill | Tel: 01-804 5482, e-mail: 01-804 5482 |
Media enquiries: MKC Communications: 01 7038600
Haven’t found what you’re looking for?
Scroll
Competition and Consumer Protection Commission
PO Box 12585, Dublin 1, D01 C576
Tel +353 (0)1 402 5500
Consumer helpline 01 402 5555